Monday, February 10, 2020

Study shows how extracellular vesicles help melanoma cells to spread

A new study from Finland sheds fresh light on how melanoma cells interact with other cells via extracellular vesicles they secrete. The researchers found that extracellular vesicles secreted by melanoma cells use the so-called hedgehog signaling pathway to intensify the malignant properties of the cells they are targeting. The discovery can help in the development of better treatment and diagnostics for melanoma. Published in Cellular and Molecular Life Sciences, the study was carried out in collaboration between researchers from the University of Eastern Finland and the University of Helsinki.

Many of the mechanisms regulating the function of our body have remained unchanged throughout evolution. This means that the same genes regulate the development and function of all multicellular animals. One example of such gene survival is the so-called hedgehog signaling pathway. The gene family associated with this signaling pathway gets its unique name from a mutation it caused in fruit fly larvae, making them look spiky, just like a hedgehog. The most common of the three hedgehog genes found in mammals, the Sonic hedgehog gene, was aptly named after the famous video game character. In mammals, members of the hedgehog gene family are essential regulators of fetal development, but they are also associated with stem cell division in later stages of development and even in adults. Recent studies suggest that their expression is also associated with many different types of cancer, including skin cancers. Melanoma is the most severe form of skin cancer, and it is becoming more and more common.


Extracellular vesicles carry signals between cells - and they can also carry packaged drugs

Traditionally, signaling in the body is thought to take place via freely circulating signals, such growth factors and hormones. According to a more recent view, however, it is believed that some signals are packaged for transportation to protect them against breakage and to ensure their delivery to the correct address. Extracellular vesicles are small, bubble-like packages made of cell membrane, serving as natural carriers of signals in the body. They regulate the function of the body already during the fetal stage, via breast milk and also later in life as our tissue regenerates. Cancer cells, too, use extracellular vesicles to deliver signals and to modify their environment, making it favorable to growth. Extracellular vesicles can also be used as diverse carriers of drugs to combat diseases and to repair tissue damage - and this is why they are being studied so actively at the moment.


In the newly published study, the researchers discovered a new link between extracellular vesicles and hedgehog molecules. They found that vesicles secreted by melanoma cells intensify the malignant properties of the cells they are targeting, such as division and spreading, via the hedgehog signaling pathway. The researchers used cultured human melanoma cells and normal skin cells, confirming their findings from the cell culture by analyzing tissue samples from patients with melanoma.

It is quite a coincidence that these signal-carrying vesicles originate from cells that are also known as hedgehog cells due to their microscopically small, spike-like protrusions. These protrusions, however, don't have anything to do with fruit fly larvae; instead, they are typically found in cells that are active in producing hyaluronan, the most common sugar molecule in the extracellular matrix. Hyaluronan also plays a key role in vesicle mediated signaling, as hyaluronan found on the surface of vesicles protruding from the cell surface facilitates their binding to the target cell."  Docent Kirsi Rilla, University of Eastern Finland

The hedgehog signaling pathway holds great promise as a target for drug therapy in melanoma and other cancers. The regulation mechanism now discovered by the researchers can be made use of in the development of better diagnostics and drug therapy for patients with melanoma.

Docent Rilla's research group has been studying the biology of extracellular vesicles since 2013.


This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.     
https://gscrochetdesigns.blogspot.com. one can see my crochet creations  
https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes    
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement
 

Labels: , , , , , , , , ,

Sunday, March 04, 2018

Just One Psychedelic Drug Trip Can Cause Changes In Personality That Could Last Years

Psychedelics, such as magic mushrooms, LSD and ayahuasca, are known to have powerful effects on the brain, which can significantly alter consciousness. But how do these substances affect our minds in the long-term?

A new review of studies, has found that even a single psychedelic trip can lead to changes in personality that can potentially last for years.

A team of researchers from Brazil and Spain analyzed 18 studies conducted between 1985 and 2016, all of which examined the relationship between the use of psychedelics and changes in personality.

Most of these studies primarily focused on three substances: LSD (lysergic acid diethylamide), psilocybin (the psychoactive compound in magic mushrooms) and ayahuasca (a powerful hallucinogenic brew, used ritually by the indigenous people of the Amazon).

These drugs produce their effects by binding to receptors of serotonin—a brain chemical which has an influence on our moods and appetites—resulting in hallucinations, euphoria and a host of other sensations.

After reviewing the studies, the researchers found that people who took these substances experienced long-term, perhaps even permanent, personality changes compared to people who had never taken them.

For example, the review found that participants in clinical trials who were given a small dose of psychedelics were rated as having more openness than non-users following their trip. In psychological terms, openness—one of the five main personality traits—is made up of different facets including appreciation of new experiences, attentiveness to inner feelings and intellectual curiosity.

“Psychedelic drug users and non-users appear to differ in some personality traits,” the authors wrote in their review. “Psychedelics administered in controlled settings may induce personality changes, such as increased Openness and Self-Transcendence.”

Furthermore, these changes in personality were beneficial, having a therapeutic and antidepressant effect on the individuals in question, according to findings from a number of the studies analyzed. These effects were felt, in some cases, for a year or longer.

While the link between psychedelics and personality changes has been investigated by scientists since the 1950s at least, for the latest review, the researchers chose to focus on studies published after 1985 as this period witnessed a significant rise in both the number, and quality, of reports looking into this question.

It is important to note, however, that it is difficult to draw concrete conclusions regarding the link between psychedelics and long-term personality changes, as many of the studies involved small numbers of participants.

THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.    
PS- THOSE INTERESTED IN RECIPES ARE FREE TO VIEW MY BLOG-                      
HTTP:GSEASYRECIPES.BLOGSPOT.COM/
FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                                    
HTTP://KNEE REPLACEMENT-STICK CLUB.BLOGSPOT.COM/
FOR CROCHET DESIGNS

HTTP://MY CROCHET CREATIONS.BLOGSPOT.COM

Labels: , , , , , , , , , ,

Saturday, February 17, 2018

This Common Medication Can Actually Prevent Type 1 Diabetes

There's new hope for stopping Type 1 diabetes in its tracks after researchers discovered an existing drug can prevent the condition from developing – and the same techniques used here could also be applied to other diseases.

The drug in question is methyldopa, currently on the World Health Organisation's list of essential drugs having been used for more than 50 years to treat high blood pressure in pregnant women and children.

By running an analysis of thousands of drugs through a supercomputer, the team of researchers was able to pinpoint methyldopa as a drug able to block the DQ8 molecule. The antigen is found in a proportion of the population and has been implemented in auto immune responses.

It appears in some 60 percent of people at risk from developing Type 1 diabetes.

"This is the first personalised treatment for Type 1 diabetes prevention," says one of the team member. "This is very significant development."

Based on the supercomputer calculations, the scientists found that methyldopa not only blocked the binding of DQ8 but didn't harm the immune functions of other cells, which is often the case with drugs that intefere with the body's immune system.

Overall, the research covered a period of 10 years – after the supercomputer analysis, the drug was tested in mice and in 20 patients with Type 1 diabetes through a clinical trial. The new drug is taken orally, three times a day.

While it's not a full cure (work on that continues), methyldopa could help delay, or even limit the onset of Type 1 diabetes – a disease that currently starts mostly in childhood.

"We can now predict with almost 100 percent accuracy who is likely to get Type 1 diabetes, says a researcher. "The goal with this drug is to delay or prevent the onset of the disease among those at risk."

That 100 percent prediction rate is made possible by looking at a variety of genetic and biological markers, including auto-antibodies in the blood. Those at risk could now be put on a course of treatment to ward off the development of diabetes.

With diagnosed cases of Type 1 and Type 2 diabetes on the rise in the United States – and the Type 1 condition believed to affect around 1.25 million people in the US alone – such treatments could make a huge difference.

Accounting for about 5-10% of people with diabetes, Type 1 involves the body's own immune system attacking the pancreas, stopping the production of insulin and hampering the absorption of glucose and the production of energy.

In Type 2 diabetes, the body can't process the insulin it does make properly.

Methyldopa is far from the first drug to show benefits in treating health issues other than the ones it was first designed for, but we now have better ways to spot these extra powers: this idea of identifying certain molecules and then applying modern-day computing power to find drugs that block them could work in other situations too.

"This study has significant implications for treatment of diabetes and also other autoimmune diseases," says one of the researchers.

"This study suggests that the same approach may be adapted to prevent autoimmune diseases such as rheumatoid arthritis, celiac disease,multiple sclerosis, systemic lupus erythematosus and others."


THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.    

PS- THOSE INTERESTED IN RECIPES ARE FREE TO VIEW MY BLOG-                      
HTTP:GSEASYRECIPES.BLOGSPOT.COM/
FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                                     
HTTP://KNEE REPLACEMENT-STICK CLUB.BLOGSPOT.COM/
FOR CROCHET DESIGNS

HTTP://MY CROCHET CREATIONS.BLOGSPOT.COM

Labels: , , , , , , , , , , , , ,